2 chapters across the catalog
Ozempic Rebound, Insulin Resistance, and Producer Love
The final segment touches on the "Ozempic rebound" and the marketing of weight loss drugs. A musical mix addresses metabolic issues and insulin resistance. The hosts end with a message of support for producers regardless of their physical size or health struggles, emphasizing that they value their community's contributions above all else.
Salt Institute Claims and the Obesity Epidemic
A representative from the Salt Institute argues that federal dietary guidelines recommending low salt intake may be counterproductive and discriminatory. Research from Harvard Medical School is cited, suggesting that low-salt diets can increase insulin resistance, a precursor to type 2 diabetes. Furthermore, the theory posits that reducing salt leads to increased caloric consumption as the body attempts to satisfy its innate salt appetite, potentially worsening the obesity crisis.
